Fundraising FoxAlta Life Sciences — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients.
BiotechDigital HealthMedical Devices
BoardProf Rob E. Coleman(Chairman)
Co-investorsAsabys PartnersCriteria Bio VenturesYsios Capital
Mediktor is an AI-powered healthcare chatbot platform that enables patients to assess symptoms and receive preliminary guidance through natural language conversations.
AI & Machine LearningDigital HealthHealthtechBarcelona, ES
Oscar García-Esquirol(Co-founder / Medical Director)inCristian Pascual(Founder)inRoger Forcada(CTO)in
Co-investorsAsabys Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.